Human Salusin Beta (SALb) ELISA kit

Salusin-beta is a vasoactive peptide generated by proteolytic cleavage of the preprosalusin precursor encoded by the TOR2A gene, and it has emerged as a peptide of interest in cardiovascular and metabolic research. Studies have examined its role in blood pressure regulation, endothelial dysfunction, inflammatory cascades, and the progression of atherosclerotic lesions, making quantitative measurement of circulating levels relevant to investigations of hypertension, coronary artery disease, and chronic kidney disease.

This Assay Genie product is a competitive ELISA configured for 96-assay microplate workflows with a colorimetric endpoint, allowing laboratories running routine biomarker panels to incorporate Salusin-beta quantification without dedicated instrumentation beyond a standard plate reader. The kit ships with pre-coated plate strips and the assay reagents required to complete a full plate run, and is intended for in vitro research use with human-derived specimens including patient sera and tissue-derived extracts.

The competitive format suits small peptide targets where sandwich-style capture is impractical, and the colorimetric readout integrates easily with existing ELISA readers set to the appropriate wavelength for HRP-based detection. It is aimed at research laboratories studying vasoactive peptides, endothelial biomarkers, and cardiometabolic disease mechanisms.